Internal Medicine, Hematology & Oncology · Little Rock, AR
NPI
1205844594
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
10001 Lile Dr
Little Rock, AR, 72205
Phone (501) 552-6100
Medicare paid, 2024
$78K
3,838 services
Medicare patients, 2024
240
Average age 74
Drug cost, 2024
$1.8M
523 prescriptions
Company payments, 2025
$3,751
From 44 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter D Emanuel was code 36415 (venipuncture blood collection), 653 times for 196 patients. In total Peter D Emanuel billed 3,838 services in 45 codes, and Medicare paid $78K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 653 | 196 | $8.65 | $5,648 |
| 85025 Blood Count | Office | 650 | 196 | $7.60 | $4,939 |
| 99213 Office E&M - Established | Office | 616 | 188 | $59.33 | $37K |
| 80053 Clinical Chemistry | Office | 611 | 196 | $10.35 | $6,324 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 437 | 137 | $11.60 | $5,070 |
| 99232 Hospital E&M - Subsequent | Facility | 120 | 41 | $56.65 | $6,797 |
| 83615 Clinical Chemistry | Office | 112 | 56 | $5.92 | $663 |
| 82728 Clinical Chemistry | Office | 83 | 47 | $13.36 | $1,109 |
| 84550 Clinical Chemistry | Office | 78 | 35 | $4.43 | $346 |
| 83550 Clinical Chemistry | Office | 77 | 44 | $8.57 | $660 |
| 83540 Clinical Chemistry | Office | 77 | 44 | $6.34 | $488 |
| 85045 Blood Count | Office | 63 | 40 | $3.91 | $246 |
| 99222 Hospital E&M - Initial | Facility | 38 | 34 | $91.04 | $3,460 |
| 83735 Clinical Chemistry | Office | 22 | 11 | $6.57 | $145 |
| 82607 Clinical Chemistry | Office | 19 | 15 | $14.78 | $281 |
By year: 2022 $76K for 3,062 services; 2023 $75K for 3,300 services; 2024 $78K for 3,838 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 653 | 196 | $8.65 | $5,648 |
| 85025 Blood Count | 650 | 196 | $7.60 | $4,939 |
| 80053 Clinical Chemistry | 611 | 196 | $10.35 | $6,324 |
| 83615 Clinical Chemistry | 112 | 56 | $5.92 | $663 |
| 82728 Clinical Chemistry | 83 | 47 | $13.36 | $1,109 |
| 84550 Clinical Chemistry | 78 | 35 | $4.43 | $346 |
| 83550 Clinical Chemistry | 77 | 44 | $8.57 | $660 |
| 83540 Clinical Chemistry | 77 | 44 | $6.34 | $488 |
| 85045 Blood Count | 63 | 40 | $3.91 | $246 |
| 83735 Clinical Chemistry | 22 | 11 | $6.57 | $145 |
Medicare prescription drug claims, 2024
In 2024, the drug Peter D Emanuel prescribed most often to Medicare patients was Eliquis (Apixaban), with 58 prescriptions and refills. In total Peter D Emanuel wrote 523 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 58 | 78 | 12 | $44K |
| Venclexta Venetoclax | 40 | 40 | Under 11 | $484K |
| Hydroxyurea Generic | 36 | 76 | Under 11 | $913 |
| Anastrozole Generic | 36 | 50 | Under 11 | $414 |
| Prednisone Generic | 25 | 29 | Under 11 | $66.15 |
| Potassium Chloride Generic | 20 | 40 | Under 11 | $212 |
| Xarelto Rivaroxaban | 14 | 14 | Under 11 | $7,938 |
| Folic Acid Generic | 13 | 21 | Under 11 | $51.43 |
| Tasigna Nilotinib Hcl | 13 | 13 | Under 11 | $244K |
| Granix Tbo-Filgrastim | 13 | 13 | Under 11 | $39K |
| Calquence Acalabrutinib Maleate | 12 | 12 | Under 11 | $187K |
| Warfarin Sodium Generic | 11 | 33 | Under 11 | $166 |
Brand drugs: 191 claims; generic drugs: 332 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter D Emanuel $3,751 ($3,751 in general payments such as food, travel and fees) from 44 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $292.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 9 | $292 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $246 |
| Merck Sharp & Dohme LLC MRK | 8 | $190 |
| Incyte Corporation INCY | 12 | $188 |
| EMD Serono, Inc. MRK.DE | 8 | $185 |
| Daiichi Sankyo Inc. 4568.T | 9 | $177 |
| Celgene Corporation BMY | 16 | $170 |
| Pfizer Inc. PFE | 10 | $169 |
| Exelixis Inc. EXEL | 8 | $153 |
| Alnylam Pharmaceuticals Inc. ALNY | 11 | $148 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.